awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36266449-453BFA75-9E63-471D-8E21-E3C9E3EE7497
Q36266449-453BFA75-9E63-471D-8E21-E3C9E3EE7497
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36266449-453BFA75-9E63-471D-8E21-E3C9E3EE7497
The frequency and clinical impact of HER2 alterations in lung adenocarcinoma.
P2860
Q36266449-453BFA75-9E63-471D-8E21-E3C9E3EE7497
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36266449-453BFA75-9E63-471D-8E21-E3C9E3EE7497
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
14aeaf9ef766af73a0dbbe9c192124958d05d25b
P2860
Randomized phase II trial of gemcitabine-cisplatin with or without trastuzumab in HER2-positive non-small-cell lung cancer.